For research use only
| Cat No. | ABC-TC0161 |
| Product Type | Human Myeloma Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Multiple Myeloma |
| Product Code | COLO-677, Human Melanoma Cell Line COLO-677, COLO 677, COLO677, COLO-0677, Human Cutaneous Melanoma Cells, Skin Cancer Cell Line |
The COLO-677 cell line provides a human colorectal cancer model for drug screening, tumor biology studies, and molecular mechanism research.
COLO-677 was initially misidentified but is now confirmed to be a derivative of the multiple myeloma line RPMI-8226. The cells were originally derived from a tumor in the left axillary lymph node of a 39-year-old male with small cell lung carcinoma in 1989. COLO-677 cells exhibit suspension growth properties. Although originally reported as a small cell lung cancer cell line, COLO-677 is a multiple myeloma derivative and is among the 12 cell lines with S100A14 mRNA expression, though the specific expression level is not specified. This cell line can be used in in vitro tumorigenicity studies. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | COLO-677, Human Melanoma Cell Line COLO-677, COLO 677, COLO677, COLO-0677, Human Cutaneous Melanoma Cells, Skin Cancer Cell Line |
| Species | Human |
| Cat.No | ABC-TC0161 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Multiple Myeloma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Myeloma Cell Lines |
The COLO-677 cell line is widely used and holds significant value in multiple myeloma research. It provides an ideal in vitro model for exploring disease mechanisms and for gaining deeper insight into the complex pathogenesis of multiple myeloma, helping to reveal key processes such as intracellular signal transduction and gene regulation. It also supports research into multiple myeloma and related cancer biology, contributing to studies of tumor biology and molecular regulatory mechanisms.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
